Bullous mastocytosis

Journal of Clinical Dermatology

Volumn 36, Issue 1, 2007, Pages 26-27

  Fan, Ping Shen ^a   Fu, Meng ^a   Liao, Wen Jun ^a   Hu, Xue Hui ^a   Gao, Tian Wen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bullous; Cromoglycate; Disodium; Urticaria pigmentosa

Indexed keywords

CROMOGLYCATE DISODIUM; HISTAMINE H1 RECEPTOR ANTAGONIST; PREDNISONE;

ARTICLE; BLISTER; CASE REPORT; DRUG RESPONSE; EPIDERMIS; FEMALE; GIEMSA STAIN; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; INFLAMMATORY CELL; MASTOCYTOSIS; PRURITUS;

EID: 33847284396     PISSN: 10004963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Buttner C, Henz BM, Welker P, et al. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior[J]. J Invest Dermatol, 1998, 111(6): 1227-1231.
2. Chinese source.
3. Chinese source.
4. Murphy M, Walsh D, Drumm B, et al. Bullous mastocytosis: a fatal outcome[J]. Pediatr Dermatol, 1999, 16(6): 452-455.
5. Stege H, Schopf E, Ruzicka T, et al. High-dose UVA1 for urticaria pigmentosa[J]. Lancet, 1996, 347(8993): 64.